Sono-Tek Corp (SOTK)
NASDAQInformation TechnologyIndustrial - MachinerySnapshot 2026-09-04
$5.02+0.80%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologyIndustrial - MachinerySnapshot 2026-09-04
QuarterlyIQ Insights · SOTK
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -24.9% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 7.7% |
Growth built into the price is above our model estimate.
The price assumes 32.6 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 64 industry peers
SOTK — earnings in line
Dated 2026-08-20
and Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Why it matters: Any change in revenue guidance shows what management thinks about the market. This can affect investor trust.
Watch forManagement raises revenue growth guidance for FY 2027.
Also watch forManagement lowers revenue growth guidance for FY 2027.
Why it matters: Positive cash flow from operations shows good financial health. It helps support growth investments.
Supportive ifCash from operations is positive in Q1 of fiscal 2027.
Worry ifCash from operations is negative in Q1 of fiscal 2027.
Why it matters: Stable clean energy revenue is coming back after declines. This helps overall growth.
Watch forClean energy revenue is stable or growing compared to past quarters.
Also watch forClean energy revenue keeps declining. This shows ongoing challenges.
Why it matters: Strong medical revenue growth shows demand for Sono-Tek's products. It supports their growth strategy.
Supportive ifMedical revenue growth exceeds 50% year over year in Q1 fiscal 2027.
Worry ifMedical revenue growth falls below 50% year over year in Q1 fiscal 2027.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$208 on $10,000 · ±2.1% | How much price usually moves either way. |
| Bad day | $438 loss on $10,000 · 4.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,389 loss on $10,000 · 23.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: A decline would indicate weakening demand in a key growth area for Sono-Tek.
Worry ifMedical sector revenue is below $3.95 million. This shows a big drop.
Less concerning ifIf medical sector revenue stays stable or grows, it shows strong demand.
Why it matters: Sector growth impacts Sono-Tek. A drop may signal broader issues in the market.
Worry ifSector revenue growth reported below its median.
Less concerning ifSector revenue growth remains at or above its median.
Why it matters: Strong cash flow from operations helps support growth and financial health.
Supportive ifCash from operating activities was more than $2 million in Q2.
Worry ifCash from operating activities fell below $1.94 million. This shows cash flow issues.
Why it matters: A growing backlog shows strong demand for the future. It also shows stability in operations.
Supportive ifBacklog was above $8 million. This shows strong order intake.
Worry ifBacklog dropped below $7.73 million. This signals possible demand issues.
Why it matters: High gross margins show good cost management. They also reflect a strong product mix.
Supportive ifGross margin was over 55%. This shows the company runs well.
Worry ifGross margin fell below 55%. This suggests possible cost pressures.
Why it matters: Improving cash flow is a key goal. A decline could raise concerns about operations.
Worry ifCash from operations is below $1M.
Less concerning ifCash from operating activities is at or above $1M.
Why it matters: Over 10% revenue growth shows strong demand. This is especially true in the medical sector.
Supportive ifQ2 revenue growth reported above 10% compared to the prior year.
Worry ifQ2 revenue growth falls below 5% compared to the prior year.
Why it matters: Gross margin above 55% shows good cost control. It also means high-value sales.
Supportive ifGross margin reported above 55% for Q2.
Worry ifGross margin falls below 50% for Q2.
Why it matters: Growth in the medical sector shows strong demand. It also means successful market entry.
Supportive ifMedical sales grew over 50% compared to last year.
Worry ifMedical sales growth is below 30% compared to last year.
Why it matters: A stable backlog shows future revenue and steady demand.
Supportive ifBacklog is over $8 million.
Worry ifBacklog falls below $7 million.